Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2021-02-26Clinical Trial Update: The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening [NA]
A completed clinical trial evaluating the effect of an electronic medical record alert on hepatitis B screening uptake.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent [Phase 2]
Phase 2 trial comparing Myrcludex B plus peginterferon alfa-2a versus peginterferon alfa-2a alone in chronic hepatitis B with delta-agent; r…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 trial update on ACH-126,443 (Beta-L-Fd4C) in treatment-naive adults with chronic hepatitis B exploring safety and antiviral activity…
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients [Phase 2]
Phase 2 trial update evaluating safety and efficacy of T101 adenovirus injection with nucleoside analogues in chronic hepatitis B patients; …
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Arresting Vertical Transmission of Hepatitis B Virus [Phase 4]
Phase 4 trial update on strategies to prevent vertical transmission of hepatitis B, with completed results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV) [Phase 2]
A Phase 2 trial evaluating ABI-H0731+Entecavir versus Entecavir alone in viremic HBeAg-positive chronic hepatitis B showed completion and po…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection [Phase 2]
Phase 2 trial of ABI-H0731 as adjunctive therapy in chronic hepatitis B has completed with results posted.
-
EMA withdrawal · 2021-01-14EMA Withdrawn: Sebivo (telbivudine) — Novartis Europharm Limited
Withdrawal of Sebivo (telbivudine) from the market by Novartis Europharm Limited for chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults [Phase 4]
Phase 4 trial update on the immunogenicity of hepatitis B vaccination in HIV-infected adults with results posted.
-
CLINICAL_TRIALS research · 2021-01-14Clinical Trial Update: New Methods to Measure the Immune Response to Hepatitis B Vaccine [Phase 4]
Phase 4 clinical trial updating methods to measure immune response to Hepatitis B vaccine.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment [Phase 2]
Phase 2 study evaluating safety, tolerability, and antiviral activity of Selgantolimod (GS-9688) in viremic adults with chronic hepatitis B …
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of RO7062931 in healthy volunteers and chronic hepatiti…
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Tenofovir Alafenamide in HBV Related Decompensated Liver [Phase 4]
Phase 4 clinical trial update for Tenofovir Alafenamide in HBV-related decompensated liver disease.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury. [Phase 4]
Phase 4 trial updating on effectiveness and safety of tenofovir alafenamide in chronic hepatitis B patients with mildly elevated ALT and sig…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection [Phase 2]
A Phase 2 study assessing safety, tolerability, pharmacokinetics, and antiviral activity of IONIS-HBVRx in treatment-naïve chronic hepatitis…
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetics study assessing tenofovir alafenamide (TAF) in adults with normal hepatic function and those with severe hepatic im…
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus [Phase 4]
Phase 4 clinical trial update on maternal screening and antiviral therapy to reduce mother-to-infant transmission of hepatitis B virus.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test [Phase 4]
Phase 4 clinical trial update evaluating antiviral therapy in pregnant women to reduce mother-to-infant transmission of hepatitis B virus.
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Immunity to Hepatitis B Vaccine [Phase 4]
Phase 4 trial update on immunity to Hepatitis B vaccine completed.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides [Phase 4]
Phase 4 trial update evaluating TAF in patients with suboptimal response to other nucleos(t)ides for chronic hepatitis B; efficacy and safet…
-
FDA approval · 2020-11-13FDA Approved: ENTECAVIR — Supplemental Application (Solco Healthcare LLC)
FDA approved Solco Healthcare LLC's supplemental application for ENTECAVIR (entecavir) under ANDA208782.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB [Phase 1, Phase 2]
Phase 1/2 trial evaluating HB-Vac Activated-DCs with Peg-IFN or nucleos(t)ide analogues in chronic hepatitis B has completed.
-
FDA approval · 2020-10-26FDA Approved: ADEFOVIR DIPIVOXIL — Supplemental Application (Sigmapharm Laboratories, LLC)
FDA approved a supplemental application for Adefovir Dipivoxil from Sigmapharm Laboratories, LLC.
-
CLINICAL_TRIALS research · 2020-10-26Clinical Trial Update: Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania [NA]
Clinical trial update reporting prevalence of hepatitis B in pregnant women attending antenatal care in Tanzania; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients [Phase 2]
Phase 2 clinical trial updating efficacy and safety of HLX10 in chronic hepatitis B patients.